TTD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TTD is not a good buy right now for an impatient investor. While the stock is deeply oversold and sitting near key support (S1 ~31.01 / S2 ~29.40), the primary trend is still decisively bearish (bearish moving-average stack and worsening MACD). The recent CFO turnover has become a dominant overhang and has driven broad price-target cuts, meaning the stock can stay “cheap” or keep sliding without a clean technical reversal. Best stance right now is HOLD/AVOID new buying until price reclaims resistance (at least the pivot ~33.62) or a clear reversal forms—there are no Intellectia buy signals today to justify jumping in early.
Intellectia Proprietary Trading Signals
Trend remains bearish: SMA_200 > SMA_20 > SMA_5 confirms sustained downtrend. Momentum is still deteriorating with MACD histogram at -0.529 and negatively expanding. RSI_6 at 16.63 signals extreme oversold conditions, which can trigger short bounces, but oversold alone is not a buy signal in a strong downtrend. Key levels: immediate supports S1 ~31.01 and S2 ~29.40 (post-market ~30.31 is near S2 zone); resistance at pivot ~33.62, then R1 ~36.23. A higher-probability technical improvement would be a reclaim of ~33.62 and stabilization above it, otherwise rallies risk being dead-cat bounces.
can produce sharp mean-reversion bounces.
on 2026-02-25 after hours could reset the narrative if guidance/visibility improves.
CFO transition/turnover is a major credibility and execution overhang and is directly driving multiple price-target cuts.
Technical trend is firmly down (bearish MA stack + worsening MACD), increasing odds that support breaks rather than holds.
Competitive pressure narrative (notably Amazon DSP competition and AI lowering switching costs across DSPs) continues to weigh on perceived moat.
Earnings risk: market may wait for the Feb 25 call; any weak Q1 guidance/visibility could prompt another leg down.
Latest reported quarter: 2025/Q3. Revenue rose to ~$739.4M (+17.74% YoY), net income to ~$115.5M (+22.72% YoY), and EPS to $0.23 (+21.05% YoY), showing continued growth in core profitability. However, gross margin declined to ~78.07% (-2.98% YoY), which is a mild quality/mix headwind and can amplify concerns if growth slows further.
Recent trend is clearly negative: multiple firms cut price targets sharply in January 2026, largely tied to the CFO surprise and increased uncertainty/visibility concerns. Truist cut PT to $60 (Buy), Rosenblatt cut to $53 (Buy), UBS cut to $50 (Buy), Stifel cut to $74 (Buy), Citi cut to $38 (Neutral), Wells maintained Equal Weight with $42, Cantor stayed Neutral with $43, and BofA kept Underperform with $40; Citizens downgraded to Market Perform. Wall Street pros: (1) still see a path to recovery and attractive returns if growth re-accelerates, and (2) some believe valuation is more reasonable after the collapse. Wall Street cons: (1) management/CFO volatility undermines confidence and valuation premium, (2) competition and switching-cost compression risk the moat, and (3) near-term guidance/visibility is the key “show-me” issue. Politician/influential trading: no recent congress trading data available; insider trend is neutral (no notable recent signal).
